ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
0.00
0.00%
US Tech 100
21,220.00
1.09%
Dow Jones
44,156.73
0.30%
Brent Oil
78.335
0.00%
Bitcoin
103,400.36
-0.23%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Guerbet Sa (0ELV) Quote

Guerbet Sa

Guerbet Sa (0ELV)

LSE
27.775
0.00
(0.00%)
Closed January 22 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
27.775
Bid
27.10
Ask
28.45
Volume
3
0.00 Day's Range 0.00
27.775 52 Week Range 27.775
Market Cap
351.104M
Previous Close
27.775
Open
-
Last Trade
3
@
27.6
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
247
Shares Outstanding
12,641,000
Dividend Yield
-
PE Ratio
14.33
Earnings Per Share (EPS)
1.89
Revenue
799.96M
Net Profit
23.87M

About Guerbet Sa

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
www.guerbet.com
Headquarters
Villepinte, Seine-saint-denis, Fra
Founded
1990
Guerbet Sa is listed in the Medicinal Chems,botanicl Pds sector of the London Stock Exchange with ticker 0ELV. The last closing price for Guerbet was 27.78 €. Over the last year, Guerbet shares have traded in a share price range of 27.775 € to 27.775 €.

Guerbet currently has 12,641,000 shares outstanding. The market capitalization of Guerbet is 351.10 € million. Guerbet has a price to earnings ratio (PE ratio) of 14.33.

Ask ADVFN Intelligence (AI)

0ELV Latest News

More News

GUERBET : Bilan semestriel du contrat de liquidité

GUERBET : Bilan semestriel du contrat de liquidité Bilan semestriel du contrat de liquidité Villepinte, le 17 janvier 2025Au titre du contrat de liquidité confié par la société GUERBET à BNP...

January 17 2025
UK Regulatory

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2024

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2024 GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31...

January 14 2025
UK Regulatory

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2024

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2024 GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30...

December 11 2024
UK Regulatory

Guerbet annonce le lancement commercial en France d’Elucirem® (Gadopiclenol) son nouveau produit de contraste pour les examens d’imagerie par résonance magnétique (IRM).

Guerbet annonce le lancement commercial en France d’Elucirem® (Gadopiclenol) son nouveau produit de contraste pour les examens d’imagerie par résonance magnétique (IRM). Guerbet annonce le...

November 20 2024
UK Regulatory

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2024

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2024 GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31...

November 13 2024
UK Regulatory

GUERBET : Calendrier financier de l'exercice 2025

GUERBET : Calendrier financier de l'exercice 2025 Calendrier financier de l’exercice 2025 Villepinte, le 31 octobre 2024 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de...

October 31 2024
UK Regulatory

GUERBET : Financial agenda for 2025

GUERBET : Financial agenda for 2025 Financial agenda for 2025 Villepinte, 31 October 2024: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is...

October 31 2024
UK Regulatory

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2024

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2024 GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au...

October 30 2024
UK Regulatory

GUERBET : Revenue at September 30, 2024.

GUERBET : Revenue at September 30, 2024. Revenue at September 30, 2024 Continued growth momentum 9-month revenue: €620.5m, up 9.6% at CER1                    In the third quarter, momentum...

October 24 2024
UK Regulatory

GUERBET : Chiffre d’affaires au 30 septembre 2024.

GUERBET : Chiffre d’affaires au 30 septembre 2024. Chiffre d’affaires au 30 septembre 2024 Maintien de la dynamique de croissance Chiffre d’affaires à 9 mois : 620,5 M€, en hausse de 9,6% à TCC1...

October 24 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10027.77527.77527.7752827.775DE
40027.77527.77527.7753827.775DE
120027.77527.77527.77524727.775DE
260027.77527.77527.77520227.775DE
520027.77527.77527.77530227.775DE
1560027.77527.77527.77581527.775DE
260-10.05-26.569729015237.82538.11671727.85069756DE

0ELV - Frequently Asked Questions (FAQ)

What is the current Guerbet share price?
The current share price of Guerbet is 27.775 €
How many Guerbet shares are in issue?
Guerbet has 12,641,000 shares in issue
What is the market cap of Guerbet?
The market capitalisation of Guerbet is EUR 351.1M
What is the 1 year trading range for Guerbet share price?
Guerbet has traded in the range of 27.775 € to 27.775 € during the past year
What is the PE ratio of Guerbet?
The price to earnings ratio of Guerbet is 14.33
What is the cash to sales ratio of Guerbet?
The cash to sales ratio of Guerbet is 0.43
What is the reporting currency for Guerbet?
Guerbet reports financial results in EUR
What is the latest annual turnover for Guerbet?
The latest annual turnover of Guerbet is EUR 799.96M
What is the latest annual profit for Guerbet?
The latest annual profit of Guerbet is EUR 23.87M
What is the registered address of Guerbet?
The registered address for Guerbet is 15 RUE DES VANESSES, VILLEPINTE, SEINE-SAINT-DENIS, 93420
What is the Guerbet website address?
The website address for Guerbet is www.guerbet.com
Which industry sector does Guerbet operate in?
Guerbet operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M

Discussion

View Full Feed
FACT-MASTER FACT-MASTER 3 minutes ago
INDO: INDO Investor conference Call Jan 21 2025

https://www.dropbox.com/scl/fi/ahr5s80cp7cpzuvsjbbpt/INDO-Investor-conference-Call-Jan-21-2025-1.mp3?rlkey=jv6f6bnko3t0wtal6nzoku6nq&e=2&st=hro5afda&dl=0
INDO
k9narc k9narc 3 minutes ago
He won't last that long.
gimmee greenbacks gimmee greenbacks 4 minutes ago
“Over time, chronic inflammation can cause DNA damage and lead to cancer. For example, people with chronic inflammatory bowel diseases, such as ulcerative colitis and Crohn disease, have an increased risk of colon cancer.”


https://www.cancer.gov/about-cancer/causes-prevention/
BIEL
Slojab Slojab 4 minutes ago
Must make it hard to twirl on your fork.
manibiotech manibiotech 4 minutes ago
"Majestic mountain to climb"
Very well said . That's certainly seems to be an apt analogy 
NWBO
LORTAP KCOTS LORTAP KCOTS 4 minutes ago
Since August this stock has been trending up!! Enough said!!!
WBA
dinogreeves dinogreeves 4 minutes ago
I don't too much emphasize on them, yes they move the market for some reason, this is not a day trade for me, I am glued to it. I have price target to get to and willing to wait it out. Remember back in 2021 bought 1.5 million dollars worth of Tesla calls 3 months out, the second I bought them, th
SMCI
Halkid Halkid 5 minutes ago
Calm before the $torm, $$$
TORM
GBR GBR 5 minutes ago
That's the logical next step.


With Trump investing 500B into US private sector for AI . The smart strategy is to switch focus to Iceland.
VERI
Jimmy Joe Jimmy Joe 5 minutes ago
You've been watching too many Richard Dean Anderson series like MacGyver stardust......

🩳👜 holder. Make it up as you go.

Right, Right~?
DBMM
johnglenn johnglenn 5 minutes ago
Up 2.7% today.
ALRTF
DewDiligence DewDiligence 6 minutes ago
RFK’s nomination hearing with Senate Finance Committee scheduled_for 1/29/25:

https://www.finance.senate.gov/ranking-members-news/crapo-announces-hhs-secretary-nomination-hearing
dia76ca dia76ca 6 minutes ago
Dr. Missling keeps a lot of information to himself. We know that there is a lot going on around the world with government regulatory agencies and interested Big Pharmas! But what we can reasonably expect are the following catalysts.
1. FDA application (once new guidelines set )
2.
AVXL
ANTI-BAGHOLDER ANTI-BAGHOLDER 7 minutes ago
MONI-  style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 1.25rem"We're thrilled to share the latest updates to MyPressAlert! Between January 2 and January 21, 2025, we rolled out several enhancements aimed at making your experience f
MONI
Drugdoctor Drugdoctor 7 minutes ago
"Public Holiganism" "culture of chaos" so you admit it? On February 6, 2024, $GVSI announced that it had enter into a non-binding Term Sheet for the acquisition of a privately owned Blockchain enterprise. This evening, that company informed $GVSI by email, that it was terminating the merger effort
GVSI
ANTI-BAGHOLDER ANTI-BAGHOLDER 8 minutes ago
We're thrilled to share the latest updates to MyPressAlert! Between January 2 and January 21, 2025, we rolled out several enhancements aimed at making your experience faster, more intuitiv
MONI
Drugdoctor Drugdoctor 8 minutes ago
"Public Holiganism" "culture of chaos" so you admit it? On February 6, 2024, $GVSI announced that it had enter into a non-binding Term Sheet for the acquisition of a privately owned Blockchain enterprise. This evening, that company informed $GVSI by email, that it was terminating the merger effort
GVSI
Gmenfan Gmenfan 8 minutes ago
Apparently it's OK if it's from the left!

https://media.gettr.com/group8/getter/2025/01/22/13/390dd5e8-169f-532e-8419-df6ebd117045/dbfe512a354a634abc994bc0643c57ce_768x0.jpg
mick mick 8 minutes ago
Trumps BIG Plan To Eliminate Your Personal Debt

https://youtu.be/vhHaDkveZWY

https:// youtu.be/vhHaDkveZWY
Roofus Roofus 8 minutes ago
Yeah, that’s why I would be okay with him selling the company at $1 billion right now.

And giving us over $2.00 per share guaranteed immediately.

Don’t feel like waiting another 3,000 days.
RDGL
Gmenfan Gmenfan 8 minutes ago
Apparently it's OK if it's from the left!

https://media.gettr.com/group8/getter/2025/01/22/13/390dd5e8-169f-532e-8419-df6ebd117045/dbfe512a354a634abc994bc0643c57ce_768x0.jpg
DayitiFromMTL DayitiFromMTL 9 minutes ago
Yes
WNFT
Bull_Dolphin Bull_Dolphin 9 minutes ago
Hard hats are in order. LOL
SSKILLZ1 SSKILLZ1 9 minutes ago
~~COMPX 1/23/2025~~~~~~~

Previous Close

20009.34 +252.56

19899 SSKILLZ1
COMP
PioneerUniverse8 PioneerUniverse8 9 minutes ago
are shares attributed to integrated core strategies part of those 1.31M or is it new position?
ENTA

Your Recent History

LSE
0ELV
Guerbet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads